Jose Lobo

2.4k total citations · 1 hit paper
8 papers, 1.6k citations indexed

About

Jose Lobo is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jose Lobo has authored 8 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Jose Lobo's work include Colorectal Cancer Treatments and Studies (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and CAR-T cell therapy research (2 papers). Jose Lobo is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and CAR-T cell therapy research (2 papers). Jose Lobo collaborates with scholars based in United States, Canada and Portugal. Jose Lobo's co-authors include Neal Rosen, David B. Solit, Qing Ye, Yuhong She, Judith S. Sebolt–Leopold, Christine A. Pratilas, Andrea Basso, Iman Osman, Ayana Sawai and Gad Getz and has published in prestigious journals such as Nature, Biomaterials and Cancer Cell.

In The Last Decade

Jose Lobo

8 papers receiving 1.6k citations

Hit Papers

BRAF mutation predicts sensitivity to MEK inhibition 2005 2026 2012 2019 2005 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. BRAF mutation predicts sensitivity to MEK inhibition
    2005 1.0k citations David B. Solit, Levi A. Garraway et al. Nature profile →

Peers

Jose Lobo
Leanne Berry United States
Ahmed A. Samatar United States
Panisa Pochanard United States
Carla Milagre United Kingdom
Chris M. Jones United Kingdom
Matthias Drosten Spain
Ensar Halilovic United States
Anirudh Prahallad Netherlands
Inna V. Fedorenko United States
Katherine G. Moss United States
Leanne Berry United States
Jose Lobo
Citations per year, relative to Jose Lobo Jose Lobo (= 1×) peers Leanne Berry

Countries citing papers authored by Jose Lobo

Since Specialization
Citations

This map shows the geographic impact of Jose Lobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jose Lobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jose Lobo more than expected).

Fields of papers citing papers by Jose Lobo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jose Lobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jose Lobo. The network helps show where Jose Lobo may publish in the future.

Co-authorship network of co-authors of Jose Lobo

This figure shows the co-authorship network connecting the top 25 collaborators of Jose Lobo. A scholar is included among the top collaborators of Jose Lobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jose Lobo. Jose Lobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Harmsen, Stefan, Emin İlker Medine, Maxim A. Moroz, et al.. (2020). A dual-modal PET/near infrared fluorescent nanotag for long-term immune cell tracking. Biomaterials. 269. 120630–120630. 50 indexed citations
2.
Lobo, Jose, et al.. (2020). Management of skin adverse reactions in oncology. Journal of Oncology Pharmacy Practice. 26(7). 1703–1714. 9 indexed citations
3.
Shukla‐Dave, Amita, Mireia Castillo-Martín, Ming Chen, et al.. (2016). Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling. American Journal Of Pathology. 186(12). 3131–3145. 34 indexed citations
4.
Lee, Jason T., Hanwen Zhang, Maxim A. Moroz, et al.. (2016). Comparative Analysis of Human Nucleoside Kinase-Based Reporter Systems for PET Imaging. Molecular Imaging and Biology. 19(1). 100–108. 17 indexed citations
5.
Solit, David B., Elmer Santos, Christine A. Pratilas, et al.. (2007). 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition. Cancer Research. 67(23). 11463–11469. 48 indexed citations
6.
She, Qing‐Bai, et al.. (2005). The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell. 8(4). 287–297. 352 indexed citations
7.
Solit, David B., Levi A. Garraway, Christine A. Pratilas, et al.. (2005). BRAF mutation predicts sensitivity to MEK inhibition. Nature. 439(7074). 358–362. 1013 indexed citations breakdown →
8.
Solit, David B., Yuhong She, Jose Lobo, et al.. (2005). Pulsatile Administration of the Epidermal Growth Factor Receptor Inhibitor Gefitinib Is Significantly More Effective than Continuous Dosing for Sensitizing Tumors to Paclitaxel. Clinical Cancer Research. 11(5). 1983–1989. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leanne Berry Breakdown of academic impact, for papers by Ahmed A. Samatar Breakdown of academic impact, for papers by Panisa Pochanard Breakdown of academic impact, for papers by Carla Milagre Breakdown of academic impact, for papers by Chris M. Jones Breakdown of academic impact, for papers by Matthias Drosten Breakdown of academic impact, for papers by Ensar Halilovic Breakdown of academic impact, for papers by Anirudh Prahallad Breakdown of academic impact, for papers by Inna V. Fedorenko Breakdown of academic impact, for papers by Katherine G. Moss
Rankless by CCL
2026